Texas Instruments: Paying 38 times trough-adjusted earnings for a cyclical recovery that is already half-priced

Stevie AI on Texas Instruments Incorporated (TXN-USA | texasinstrum)

10/27/2026

Summary

Texas Instruments designs and manufactures analog and embedded processing semiconductors sold into industrial, automotive, data-center, personal electronics, and communications end markets, operating owned 300mm fabs concentrated in the United States. The structural insight is that TI is executing a genuine cyclical recovery off a FY2025 trough, layered on top of a long-duration capex cycle that has suppressed free cash flow per share for several years; the market is now pricing that recovery as if margin expansion and volume growth are both guaranteed and imminent, leaving little room for the macro deterioration management itself has flagged in industrial and data-center demand. Revenue grew from $15.6B in FY2024 to $17.7B in FY2025, a 13% increase, while EPS grew more modestly from $5.20 to $5.45, reflecting margin pressure from elevated depreciation tied to capacity investment outpacing the fall-through benefit of higher volumes. Net income rose from $4.8B to $5.0B, a much slower pace than revenue growth, underscoring that the company is still absorbing the cost of its capacity build rather than harvesting full operating leverage. Applying a 28x multiple to FY2028 EPS of $7.13 — a premium analog/embedded franchise multiple reflecting TI's quality but below pure-growth semiconductor peers given TI's single-digit-to-low-teens growth profile — yields a price target of approximately $199.60, discounted back to roughly $164.98 for FY2026 and $181.48 for FY2027, and rolled forward to $221.93 for FY2029; all of these sit meaningfully below the current $298.12 price, implying the stock is pricing a more optimistic recovery and margin trajectory than the forecast supports.

Thesis

1. **Durable but Mature Competitive Position**: TI's owned 300mm fab footprint, concentrated domestically, provides a genuine cost and supply-security advantage versus fabless analog competitors reliant on foundries, and CHIPS Act support reinforces this. However, this is a scale and reliability advantage within a contested, mature market rather than a differentiated growth engine — TI itself characterizes its strategic position as a 7.0/10 'contested' market, not a blue ocean. The advantage protects margins and market share but does not by itself justify a premium multiple expansion; it is a defensive moat, not an offensive growth lever. 2. **Business Model Transition Through a Capex-Heavy Period**: TI is mid-cycle in a multi-year capacity investment program, with capex guided to the high end of $2-3B in 2026 and stepping higher through 2029 per the forecast (implied $2.9-3.5B/yr). This investment is being funded by operating cash flow plus incremental debt, with net debt rising steadily from $13.1B in FY2026 to $15.7B by FY2029. The capital intensity means free cash flow, not net income, is the more honest lens on value creation, and FCF of $5.0B-$6.5B over the forecast window grows more slowly than revenue, reflecting the ongoing depreciation drag embedded in the 75-85% incremental fall-through framework. 3. **Financial Outlook Is Recovery, Not Re-Rating**: The forecast embeds EPS growing from $5.45 (FY2025) to $7.85 (FY2029), a compound growth rate of roughly 9.5% annually — healthy but not extraordinary for a company trading near 55x trailing earnings. FY2026 guidance implies a sequential revenue decline into Q4, and the embedded assumption of continued double-digit industrial growth reversing from a mid-40s percent YoY figure is a high bar. The market appears to be extrapolating the recovery's early innings into a multi-year structural re-rating, when the underlying financial forecast shows a normal cyclical recovery trajectory, not a step-change in profitability. 4. **Mispricing Thesis — The Multiple Has Run Ahead of the Earnings Power**: At $298.12, TI trades at roughly 51x FY2026E EPS of $5.76 and 38x FY2028E EPS of $7.13. Even applying a generous 28x multiple — a premium versus the semiconductor industry average appropriate for TI's domestic manufacturing base, capital return discipline, and embedded processing margin improvement — produces fair values well below spot price across every forecast year. The gap is not explained by near-term catalysts; it reflects investors paying for a best-case convergence of secular industrial content growth, data-center tailwinds, and margin expansion simultaneously, none of which is assured given management's own acknowledgment of cyclical risk. 5. **Capital Return Framework Is Supportive But Not a Valuation Backstop at This Multiple**: Management's stated objective of growing free cash flow per share, backed by an $18.79B remaining buyback authorization, is a genuine long-term positive and will provide some share count support. But with FCF of only $5.0B in FY2026 against a market capitalization vastly larger than that figure, the buyback cannot generate enough per-share accretion to close the valuation gap on its own; it supports the downside case rather than justifying the current premium. 6. **Catalysts Are Two-Sided**: The February 2027 Q4 2026 earnings print, which will bring full 2027 guidance including capex philosophy (10% vs mid-teens growth scenarios) and demand commentary on data center and industrial post-holiday sustainability, is the key near-term event. Given the current valuation already embeds an optimistic recovery, this catalyst is more likely to disappoint than to surprise positively, particularly if industrial demand shows the cyclical softening management itself flagged as a risk.

Risks

1. **Cyclical Demand Reversal in Industrial**: Industrial end-market growth has been running above 40% YoY and represents roughly 35% of revenue; management explicitly frames this as a blend of secular and cyclical recovery. If the cyclical component — likely inventory restocking — reverses before secular drivers like content growth and IoT/robotics adoption fully offset it, revenue could decelerate sharply, and given the forecast's reliance on fall-through economics, margins and FCF would compress faster than revenue itself. 2. **Capacity Execution and Tool Supply Chain Risk**: TI's long-term capacity strategy depends on timely 300mm tool delivery; management has already flagged back-end tool availability as a tactical execution factor. Any slippage would either delay capacity-driven margin gains or force TI to run existing capacity hotter, risking quality or cost issues, while the capex spend itself continues regardless, pressuring free cash flow without the offsetting revenue benefit. 3. **Multiple Compression Risk Given Current Premium Valuation**: At roughly 51x FY2026E EPS and 38x FY2028E EPS, TI trades well above the 28x multiple this analysis considers appropriate for its growth and margin profile. Any disappointment in the recovery narrative — whether from demand, margin trajectory, or capex guidance — could trigger a de-rating toward more normalized semiconductor multiples, independent of whether the underlying earnings forecast is actually missed. 4. **Rising Net Debt Amid Capital Return Commitments**: Net debt is forecast to climb from $13.1B in FY2026 to $15.7B in FY2029, funding both capex and buybacks. If free cash flow growth disappoints relative to the $5.0B-$6.5B trajectory embedded in the forecast, TI faces a choice between curtailing shareholder returns or further levering the balance sheet, either of which would pressure the equity story. 5. **Gross Margin Framework Execution Risk**: The 75-85% incremental fall-through framework assumes disciplined cost control and utilization gains outpacing elevated depreciation from new capacity. Embedded Processing margin expansion of roughly 10 points YoY is a demanding pace to sustain; any slippage in utilization rates or mix shift away from higher-margin embedded products would directly undermine the EPS growth path from $5.76 in FY2026 to $7.85 in FY2029. 6. **Pricing Negotiation and Customer Concentration Pressure**: Annual pricing negotiations for 2027, ongoing as of early Q1 2027 per management commentary, introduce near-term uncertainty on realized pricing. In a semiconductor industry environment where customers have diversified sourcing options and inventory levels remain a swing factor, unfavorable pricing outcomes could compress the gross margin assumptions embedded in the current forecast without requiring any change in unit volumes.

📈 Price Targets